ArriVent BioPharma (AVBP) Prepaid Assets (2023 - 2026)

ArriVent BioPharma has disclosed Prepaid Assets across 4 years of filings, most recently posting $952000.0 for Q1 2026.

• Prepaid Assets for Q1 2026 came in at $952000.0, down 88.07% year-over-year; the trailing twelve-month figure through Mar 2026 was $952000.0 (down 88.07% YoY), and the FY2025 annual result was $60000.0, down 65.52% from the prior year.
• Prepaid Assets came in at $952000.0 for Q1 2026 at ArriVent BioPharma, up from $60000.0 in the prior quarter.
• In the past five years, Prepaid Assets ranged from a high of $14.5 million in Q2 2025 to a low of $60000.0 in Q4 2025.
• The 4-year median for Prepaid Assets is $4.4 million (2024), against an average of $5.0 million.
• Across the five-year window, Prepaid Assets sank 98.18% in 2024 and jumped 1841.21% in 2025, its largest moves.
• ArriVent BioPharma's Prepaid Assets stood at $9.6 million in 2023, then tumbled by 98.18% to $174000.0 in 2024, then tumbled by 65.52% to $60000.0 in 2025, then jumped by 1486.67% to $952000.0 in 2026.
• The last three Prepaid Assets figures came in at $952000.0 (Q1 2026), $60000.0 (Q4 2025), and $450000.0 (Q3 2025), per Business Quant data.